Global Hematology Analyzers and Reagents Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global Hematology Analyzers and Reagents Market is expected to grow from USD 3,563.15 Million in 2018 to USD 6,387.49 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.69%.
'Biosystems S.A., Danaher Corporation, and Abbott Laboratories are placed in forefront due to their excellence in business strategy and product satisfaction'
The positioning of the Global Hematology Analyzers and Reagents Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Hematology Analyzers and Reagents Market including are Abbott Laboratories, Bio-Rad Laboratories, Inc., Biosystems S.A., Boule Diagnostics AB, Danaher Corporation, Diatron, Drew Scientific Inc, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Horiba, Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Ortho-Clinical Diagnostics Inc, Siemens Healthcare GmbH, and Sysmex Corporation.
On the basis of Price Range, the Global Hematology Analyzers and Reagents Market is studied across High-End Hematology Analyzers, Low-End Hematology Analyzers, and Mid-Range Hematology Analyzers.
On the basis of Product & Service, the Global Hematology Analyzers and Reagents Market is studied across Hematology Products & Services, Hemostasis Products & Services, and Immunohematology Products & Services.
On the basis of End User, the Global Hematology Analyzers and Reagents Market is studied across Commercial Service Providers, Government Reference Laboratories, Hospital Laboratories, and Research and Academic Institutes.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Hematology Analyzers and Reagents Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Hematology Analyzers and Reagents Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Hematology Analyzers and Reagents Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Hematology Analyzers and Reagents Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Hematology Analyzers and Reagents Market
The report answers questions such as:
1. What is the market size of Hematology Analyzers and Reagents market in the Global?
2. What are the factors that affect the growth in the Global Hematology Analyzers and Reagents Market over the forecast period?
3. What is the competitive position in the Global Hematology Analyzers and Reagents Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Hematology Analyzers and Reagents Market?
5. What are the opportunities in the Global Hematology Analyzers and Reagents Market?
6. What are the modes of entering the Global Hematology Analyzers and Reagents Market?
'Biosystems S.A., Danaher Corporation, and Abbott Laboratories are placed in forefront due to their excellence in business strategy and product satisfaction'
The positioning of the Global Hematology Analyzers and Reagents Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Hematology Analyzers and Reagents Market including are Abbott Laboratories, Bio-Rad Laboratories, Inc., Biosystems S.A., Boule Diagnostics AB, Danaher Corporation, Diatron, Drew Scientific Inc, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Horiba, Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Ortho-Clinical Diagnostics Inc, Siemens Healthcare GmbH, and Sysmex Corporation.
On the basis of Price Range, the Global Hematology Analyzers and Reagents Market is studied across High-End Hematology Analyzers, Low-End Hematology Analyzers, and Mid-Range Hematology Analyzers.
On the basis of Product & Service, the Global Hematology Analyzers and Reagents Market is studied across Hematology Products & Services, Hemostasis Products & Services, and Immunohematology Products & Services.
On the basis of End User, the Global Hematology Analyzers and Reagents Market is studied across Commercial Service Providers, Government Reference Laboratories, Hospital Laboratories, and Research and Academic Institutes.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Hematology Analyzers and Reagents Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Hematology Analyzers and Reagents Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Hematology Analyzers and Reagents Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Hematology Analyzers and Reagents Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Hematology Analyzers and Reagents Market
The report answers questions such as:
1. What is the market size of Hematology Analyzers and Reagents market in the Global?
2. What are the factors that affect the growth in the Global Hematology Analyzers and Reagents Market over the forecast period?
3. What is the competitive position in the Global Hematology Analyzers and Reagents Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Hematology Analyzers and Reagents Market?
5. What are the opportunities in the Global Hematology Analyzers and Reagents Market?
6. What are the modes of entering the Global Hematology Analyzers and Reagents Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Hematology Analyzers and Reagents Market
3.2. Opportunities in the Hematology Analyzers and Reagents Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing blood donation
4.2.1.2. Rising incidence of blood disorders
4.2.1.3. Technological advancements
4.2.1.4. Integration of hematology analyzer with flow cytometry
4.2.2. Restraints
4.2.2.1. Product recalls and safety alerts
4.2.2.2. Slow adoption of advanced hematology instruments in emerging countries
4.2.3. Opportunities
4.2.3.1. Growing opportunities with the use of automated hematology analyzers
4.2.3.2. Market penetration opportunities in emerging countries
4.2.3.3. Rising awareness among end-users about advanced hematology analyzers
4.2.3.4. Emergence of microfluidics technology
4.2.4. Challenges
4.2.4.1. High cost of advanced hematology analyzers
4.2.4.2. Stringent and time-consuming regulatory processes significantly increasing the gestation period for product launches
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Growing Reagent Rental Business
5. GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. High-End Hematology Analyzers
5.4. Low-End Hematology Analyzers
5.5. Mid-Range Hematology Analyzers
6. GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Hematology Products & Services
6.3.1. Instruments
6.3.1.1. 5-Part and 6-Part Fully Automated Hematology Analyzers
6.3.1.2. Part Fully Automated Hematology Analyzers
6.3.1.3. Point-Of-Care Testing Hematology Analyzers
6.3.1.4. Semi-Automated Hematology Analyzers
6.3.2. Reagents & Consumables
6.3.2.1. Consumables
6.3.2.2. Controls and Calibrators
6.3.2.3. Hematology Reagents
6.3.2.4. Slide Stainers/Makers
6.3.3. Services
6.4. Hemostasis Products & Services
6.4.1. Instruments
6.4.2. Reagents & Consumables
6.4.3. Services
6.5. Immunohematology Products & Services
6.5.1. Instruments
6.5.2. Reagents & Consumables
6.5.3. Services
7. GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Commercial Service Providers
7.4. Government Reference Laboratories
7.5. Hospital Laboratories
7.6. Research and Academic Institutes
8. GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Hematology Analyzers and Reagents Market
9.2. Market Vendor Ranking Analysis for Global Hematology Analyzers and Reagents Market
9.3. Competitive News Feed Analysis for Global Hematology Analyzers and Reagents Market
10. COMPANY USABILITY PROFILES
10.1. Abbott Laboratories
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Bio-Rad Laboratories, Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Biosystems S.A.
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Boule Diagnostics AB
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Danaher Corporation
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Diatron
10.7. Drew Scientific Inc
10.8. EKF Diagnostics
10.9. F. Hoffmann-La Roche Ltd
10.10. Horiba, Ltd.
10.11. Mindray Medical International Limited
10.12. Nihon Kohden Corporation
10.13. Ortho-Clinical Diagnostics Inc
10.14. Siemens Healthcare GmbH
10.15. Sysmex Corporation
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the Hematology Analyzers and Reagents Market
3.2. Opportunities in the Hematology Analyzers and Reagents Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Increasing blood donation
4.2.1.2. Rising incidence of blood disorders
4.2.1.3. Technological advancements
4.2.1.4. Integration of hematology analyzer with flow cytometry
4.2.2. Restraints
4.2.2.1. Product recalls and safety alerts
4.2.2.2. Slow adoption of advanced hematology instruments in emerging countries
4.2.3. Opportunities
4.2.3.1. Growing opportunities with the use of automated hematology analyzers
4.2.3.2. Market penetration opportunities in emerging countries
4.2.3.3. Rising awareness among end-users about advanced hematology analyzers
4.2.3.4. Emergence of microfluidics technology
4.2.4. Challenges
4.2.4.1. High cost of advanced hematology analyzers
4.2.4.2. Stringent and time-consuming regulatory processes significantly increasing the gestation period for product launches
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
4.4.1. Growing Reagent Rental Business
5. GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. High-End Hematology Analyzers
5.4. Low-End Hematology Analyzers
5.5. Mid-Range Hematology Analyzers
6. GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Hematology Products & Services
6.3.1. Instruments
6.3.1.1. 5-Part and 6-Part Fully Automated Hematology Analyzers
6.3.1.2. Part Fully Automated Hematology Analyzers
6.3.1.3. Point-Of-Care Testing Hematology Analyzers
6.3.1.4. Semi-Automated Hematology Analyzers
6.3.2. Reagents & Consumables
6.3.2.1. Consumables
6.3.2.2. Controls and Calibrators
6.3.2.3. Hematology Reagents
6.3.2.4. Slide Stainers/Makers
6.3.3. Services
6.4. Hemostasis Products & Services
6.4.1. Instruments
6.4.2. Reagents & Consumables
6.4.3. Services
6.5. Immunohematology Products & Services
6.5.1. Instruments
6.5.2. Reagents & Consumables
6.5.3. Services
7. GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Commercial Service Providers
7.4. Government Reference Laboratories
7.5. Hospital Laboratories
7.6. Research and Academic Institutes
8. GLOBAL HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY GEOGRAPHY
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom
9. COMPETITIVE LANDSCAPE
9.1. 360iResearch FPNV Positioning Matrix for Global Hematology Analyzers and Reagents Market
9.2. Market Vendor Ranking Analysis for Global Hematology Analyzers and Reagents Market
9.3. Competitive News Feed Analysis for Global Hematology Analyzers and Reagents Market
10. COMPANY USABILITY PROFILES
10.1. Abbott Laboratories
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Bio-Rad Laboratories, Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. Biosystems S.A.
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Boule Diagnostics AB
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. Danaher Corporation
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Diatron
10.7. Drew Scientific Inc
10.8. EKF Diagnostics
10.9. F. Hoffmann-La Roche Ltd
10.10. Horiba, Ltd.
10.11. Mindray Medical International Limited
10.12. Nihon Kohden Corporation
10.13. Ortho-Clinical Diagnostics Inc
10.14. Siemens Healthcare GmbH
10.15. Sysmex Corporation
11. APPENDIX
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
